You have no items in your shopping cart.
Availability: In Stock
Save an Extra $25 on Every Buy!
Valid for all users
Glyxambi 25 mg/5 mg, manufactured by Boehringer Ingelheim and Eli Lilly and Company, is a fixed-dose combination of 2 drugs: Empagliflozin and Linagliptin. Approved by the US Food and Drug Administration (FDA) in February 2015, this drug is used with an appropriate diet and exercise program to control blood sugar levels in people with type 2 diabetes.
Both active ingredients in Glyxambi 25/5 medicine work together to increase the amount of glucose excreted in the urine and produce more insulin to lower blood sugar. Lowering and controlling blood sugar may help prevent or delay complications of diabetes, such as heart disease, kidney damage, nerve problems, loss of limbs, blindness and foot amputation.
Glyxambi 25mg/5mg are pale pink, arc triangular, flat-faced, bevel-edged, film-coated tablets. One side is debossed with the Boehringer Ingelheim company symbol, the other side is debossed with “25/5”.
Take 1 tablet once a day, with or without food. Take this diabetes medication exactly as prescribed by your doctor, including at the right times and for the full length of your prescribed treatment. Try to take it at the same time each day. Taking it at the scheduled time will have a better effect and will also help you remember when to take it.
If you forget to take Glyxambi 25 mg/5 mg
If a dose is missed, and it is 12 hours or more until the next dose, take Glyxambi 25 mg-5 mg tablet as soon as you remember. Then take your next dose at the normal time, as prescribed. If it is less than 12 hours until your next dose, the dose should be skipped and the next dose ought to be taken at the usual time. A double dose should not be taken to make up for a forgotten dose. If you have difficulty remembering your medication, ask the pharmacist for advice.
Contact your doctor or poisoning center immediately, or go to an emergency if you think that you or someone else has taken an excessive amount of Glyxambi 25/5 as prescribed. Do this even if there are no signs of discomfort or poisoning.
• Trouble sleeping
• Mouth ulceration
• Straining or pain when passing urine
• Fainting or loss of consciousness
• Skin rash
• Genital yeast infection
• Joint pain
• Elevated blood cholesterol or fat
• Store Empagliflozin 25 mg and Linagliptinat 5 mg tablet at 25°C (77°F); excursions permitted to 15°-30°C (59°-86°F).
• Avoid the bathroom cabinet. Heat and moisture from your shower, bath, and sink may damage your medicine.
• Keep this anti-diabetic medicine in its original container, tightly closed, and out of reach of children.
Drugssquare is an authorized retailer, exporter, and supplier of Glyxambi 25/5 (Empagliflozin and Linagliptin) tablets in USA (United States of America), China, Philippines, UK (United Kingdom), Malaysia, Canada, Mexico, Singapore, Canada, Sri Lanka, United Arab Emirates (UAE), Bangladesh, Vietnam, South Africa, Iran, Thailand, South Korea, Australia, Hong Kong, Indonesia, and other countries. We put patients first. If you want to purchase Boehringer Glyxambi 25/5 mg, place an order online with us today and we will deliver it directly to your door. Our specialty pharmacy strives to improve the lives of diabetic patients by providing generic diabetes medications with huge discounts and special offers.
In order to legally purchase this medicine from DrugsSquare, you’ll require a prescription from your Registered Medical Practitioner.
All content found on Drugssquare.com, including medicine uses, dosage/administration, adverse-effects, storage details are created and published online for informational purposes only. It is not intended to be a substitute for professional medical advice and should not be relied on as health or personal advice. Always consult your doctor or other qualified health professionals if you have any questions regarding your health, medicine, or medical condition. This pharmacy is present to deliver, supply, export, or dispense prescription and OTC medicines online directly to consumers/patients.